EVGN · Evogene
The AI's read
A share-price move alone says nothing about Evogene's sales, research, or cash. The article gives no company news to explain the move, so it does not change the business outlook.
The article reports Evogene shares rose 75% after hours, but gives no company news behind the move. It does not change the business outlook.
A share-price move alone says nothing about Evogene's sales, research, or cash. The article gives no company news to explain the move, so it does not change the business outlook.
The article reports AIxCrypto Holdings shares rose 6%, but gives no company news behind the move. It does not change the business outlook.
The article reports Ernexa Therapeutics shares rose 6%, but gives no company news behind the move. It does not change the business outlook.
The article reports Azitra shares rose 6%, but gives no company news behind the move. It does not change the business outlook.
The article reports Circle8 Group shares rose 5%, but gives no company news behind the move. It does not change the business outlook.
The article reports Relmada Therapeutics shares rose 5%, but gives no company news behind the move. It does not change the business outlook.
Follow Evogene (EVGN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for EVGN